Date:2/1/2012

ependence on key personnel whose continued service is not guaranteed. For a further list and description of such risks and uncertainties, see the reports filed by the company with the Securities and Exchange Commission, including the company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

'/>"/>

SOURCE BioMed Realty Trust, Inc.; Omeros Corporation Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. What Recession? How Biomedical Device Companies Thrived in a Bad Economy
2. Crux Biomedicals IVC Filter Receives CE Mark Approval
3. HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical
4. Survey of Biomedical Industry CEOs Finds Lack of Investment and Regulatory Environment Threaten Future Growth and Innovation
5. Pepex Biomedical Signs Seven Year Deal to Manufacture "Trio™"
6. Saladax Biomedical, Inc. Expands Distribution of My5-FU in Europe
7. Biomed Realty Trust to Acquire Remaining 80% Interest in Rogers Street Properties in Cambridge, Massachusetts for $308 Million - Increasing Ownership to 100%
8. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
9. U.S. Biomedical Leaders Present Leaders on Capitol Hill with New National Strategy for Innovation
10. BioMed Realty Trust Announces Public Offering Price for 22,562,922 Shares of Common Stock
11. Saladax Biomedical, Inc. Names Edward Chu, M.D., Chair of the Companys Scientific Advisory Board